Sino Biopharmaceutical dividend and valuation
Valuation
Sino Biopharmaceutical paid $0.12 per share in dividends over the last 12 months (yield 2.4%). Last ex-dividend date: September 1, 2026. The P/E ratio is 34.2. The average price target of 23 analysts is $8.49.
Data as of November 21, 2026
Sino Biopharmaceutical compared with similar companies
Sino Biopharmaceutical's P/E (trailing 12 months): 34.2, −7% against the median of a group of 8 similar companies (36.8).
| Metric | Sino Biopharmaceutical | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 34.2 | 36.8 | 32.6 – 57.4 | Middle |
| Forward P/E | 15.8 | 31.7 | 22.2 – 41.7 | Low |
| EV/EBITDA | 9.48 | 29.3 | 18.2 – 67.4 | Low |
| Price/book | 2.39 | 4.16 | 2.56 – 7.85 | Low |
| Price/sales | 2.71 | 9.88 | 5.78 – 31.6 | Low |
| Gross margin | 82.4% | 74.6% | 56.9% – 79.1% | High |
| Operating margin | 28.2% | 21.1% | 10.7% – 32.0% | Middle |
| Net margin | 7.1% | 11.1% | 7.2% – 26.8% | Low |
| ROE | 14.1% | 10.4% | 5.0% – 19.8% | Middle |
| Debt/equity | 0.37 | 0.11 | 0.05 – 0.38 | Middle |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Other metrics
Valuation multiples
- Market cap
- $91.32B
- Enterprise value
- $98.99B
- PEG
- 0.68
- EV/revenue
- 2.94
Profitability and growth
- ROA
- 7.5%
- ROIC
- 9.8%
- Revenue growth (year over year)
- 10.6%
- Earnings growth (year over year)
- 1.5%
Financial health
- Total cash
- $27.58B
- Total debt
- $17.17B
- Current ratio
- 1.63
- Quick ratio
- 1.43
- Altman Z-Score
- 3.20
- Piotroski F-Score
- 6.00
Dividends
- Annual dividend per share
- $0.12
- Dividend yield
- 2.4%
- Payout ratio
- 80.0%
- Ex-dividend date
- September 1, 2026
Analysts and estimates
- Average price target
- $8.49
- Median price target
- $8.71
- High price target
- $10.99
- Low price target
- $5.95
- Analysts with a price target
- 23
- Consensus
- Strong buy
- Forward EPS
- $0.32
- EPS estimate, current year
- $0.26
Shares and trading
- Beta
- 0.66
- Average volume
- 80.03M
- Shares outstanding
- 17.78B
- Float
- 8.73B
- Institutional ownership
- 23.1%
- Insider ownership
- 48.7%
